Procalcitonin as a diagnostic aid in osteomyelitis and septic arthritis

Yonatan Butbul-Aviel1, Ariel Koren, Raphael Halevy

  • 1Pediatric Department B, Ha'Emek Medical Center, Afula, Israel.

Pediatric Emergency Care
|December 13, 2005
PubMed

Insights

Plasma procalcitonin (PCT) is useful for diagnosing osteomyelitis in children with fever and limping. However, PCT levels were not consistently elevated in cases of septic arthritis, suggesting it is not a reliable marker for this condition.

Area of Science:

  • Pediatric Infectious Diseases
  • Biomarker Discovery
  • Skeletal Inflammatory Conditions

Background:

  • Plasma procalcitonin (PCT) is a biomarker that elevates during bacterial infections, aiding in differentiating bacterial from viral causes.
  • High PCT levels are associated with severe bacterial infections like meningitis, septic shock, bacteremia, and renal parenchymal damage.
  • Fever and limping in children can indicate serious skeletal inflammatory diseases such as osteomyelitis and septic arthritis, requiring accurate diagnosis.

Purpose of the Study:

  • To evaluate the diagnostic utility of plasma procalcitonin (PCT) analysis in pediatric patients presenting with fever and limping.
  • To differentiate between osteomyelitis, septic arthritis, and other inflammatory conditions affecting the skeletal system.
  • To assess the role of PCT as a biomarker in pediatric skeletal infections.

Main Methods:

  • Conducted a study on pediatric patients admitted with fever, limping, and suspected osteomyelitis or septic arthritis.
  • Measured white blood cell count, erythrocyte sedimentation rate, C-reactive protein, and plasma procalcitonin (PCT) levels.
  • Utilized an immunochromatography assay for PCT measurement, employing monoclonal and polyclonal antibodies against katacalcin.

Main Results:

  • Of 44 children, 12 had osteomyelitis, 11 septic arthritis, and others had soft tissue infections or other inflammatory diseases.
  • Elevated PCT levels were observed in 58.3% of osteomyelitis cases, while only 27.2% of septic arthritis cases showed mildly elevated PCT.
  • A statistically significant difference (P < 0.001) was found in PCT values between skeletal infections and other diagnoses, with no positive PCT in non-skeletal infections.

Conclusions:

  • Plasma procalcitonin (PCT) demonstrated utility as a diagnostic marker for osteomyelitis in pediatric patients.
  • PCT was found to be less reliable for diagnosing septic arthritis in this study cohort.
  • Further research with a larger patient group is recommended to validate these findings regarding PCT's role in pediatric skeletal infections.
Abstract